CRISPR Technology Market by Product (Enzymes, Kits, gRNA, Libraries, Design Tools), Service (gRNA Design, Cell Line Engineering), Application (Biomedical, Agricultural), End User (Pharma & Biopharma Companies, Academics, CROs) - Global Forecast to 2023

"The rise in government and private funding is expected to drive the overall growth of the CRISPR technology market."

The CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period. The CRISPR technology market is driven by various factors such as increasing funding and private investments and the growing adoption of CRISPR technology. However, the presence of alternate technologies can hinder the growth of the market.

"The CRISPR services segment is expected to grow at the highest CAGR during the forecast period."

The CRISPR services segment is the faster-growing segment in the CRISPR technology market, by product and service. Based on services, the CRISPR services market is segmented into gRNA design and vector construction, cell line engineering, screening services, and other CRISPR services (mediated transcriptome editing and epigenome editing services). The cell line engineering services segment is expected to grow at the highest rate.

"The biomedical applications segment, by application, is projected to hold the largest market share during the forecast period."

The major biomedical applications of CRISPR include gene therapy, drug discovery, and diagnostics. Across the globe, various gene therapy clinical trials are currently underway. These factors are expected to drive the adoption of CRISPR technology in this segment. In drug discovery applications, CRISPR is used to develop more physiologically relevant models (cell lines and animal models) that correlate better to the clinical setting and thereby reduce drug candidate failure in the initial steps. The ability of CRISPR to modify endogenous genes can help study the effect of drugs on targets along with endogenous proteins, rather than having to rely on overexpression.

"Asia Pacific is expected to record the highest growth rate during the forecast period."

Currently, 144 gene and cell therapy companies are based in the APAC that can potentially use CRISPR technology in the coming future. In China, gene editing using CRISPR has attracted strong government funding. China was among the first to allow the editing of human embryos using CRISPR-Cas9, while the US and European countries banned it. As reported by Goldman Sachs, by the end of February 2018, China had registered nine clinical trials based on CRISPR-edited cells on various diseases such as cancers and HIV infection, whereas the US had registered only one trial since the beginning of 2018.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the CRISPR technology market.

• By Company Type: Tier 1: 28%, Tier 2: 42%, and Tier 3: 30%

• By Designation: C-level Executives: 25%, Directors: 32%, and Others: 43%

• By Region: North America: 38%, Europe: 24%, APAC: 28%, and RoW: 10%

The CRISPR technology market comprises major providers such as Thermo Fisher Scientific (US), Merck KGaA (Germany), GenScript Biotech Corporation (US), Horizon Discovery (UK), Agilent (US), Cellecta (US), GeneCopoeia, Inc. (US), New England Biolabs (US), Integrated DNA Technologies (US), OriGene (US), Synthego (US) and Toolgen (S. Korea). The study includes an in-depth competitive analysis of these key players in the CRISPR technology market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

This market study covers the CRISPR technology market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, service, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will provide market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall CRISPR technology market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. OBJECTIVES OF THE STUDY
• 1.2. MARKET DEFINITION
• 1.3. MARKET SCOPE
  • 1.3.1. MARKETS COVERED
  • 1.3.2. YEARS CONSIDERED FOR THE STUDY
• 1.4. CURRENCY
• 1.5. LIMITATIONS

2. RESEARCH METHODOLOGY

• 2.1. RESEARCH DATA
  • 2.1.1. SECONDARY DATA
    • 2.1.1.1. Key data from secondary sources
  • 2.1.2. PRIMARY DATA
    • 2.1.2.1. Key data from primary sources
    • 2.1.2.2. Key industry insights
• 2.2. MARKET SIZE ESTIMATION
  • 2.2.1. BOTTOM-UP APPROACH
  • 2.2.2. TOP-DOWN APPROACH
• 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

• 4.1. CRISPR TECHNOLOGY: MARKET OVERVIEW
• 4.2. EUROPE: CRISPR TECHNOLOGY MARKET, BY END USER AND COUNTRY (2018)
• 4.3. CRISPR TECHNOLOGY MARKET, BY APPLICATIONS, 2018

5. MARKET OVERVIEW

• 5.1. INTRODUCTION
• 5.2. MARKET DYNAMICS
  • 5.2.1. DRIVERS
    • 5.2.1.1. Rising availability of government and private funding
    • 5.2.1.2. Growing adoption of CRISPR
  • 5.2.2. RESTRAINTS
    • 5.2.2.1. Off-target activity and the presence of alternative technologies
  • 5.2.3. OPPORTUNITIES
    • 5.2.3.1. Emerging markets
  • 5.2.4. CHALLENGES
    • 5.2.4.1. Ethical issues
    • 5.2.4.2. Lack of standardized regulations
    • 5.2.4.3. Pending patent issues & results of clinical trials
    • 5.2.4.4. High costs of using CRISPR
    • 5.2.4.5. Dearth of trained professionals

6. CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE

• 6.1. INTRODUCTION
• 6.2. CRISPR PRODUCTS
  • 6.2.1. GROWING R&D ACTIVITIES TO DRIVE MARKET GROWTH
  • 6.2.2. CRISPR ENZYMES
    • 6.2.2.1. Enzymes to account for the largest share of the CRISPR products market
  • 6.2.3. CRISPR LIBRARIES
    • 6.2.3.1. Growing interest of researchers in the development of novel therapies is driving the adoption of CRISPR libraries
  • 6.2.4. CRISPR KITS
    • 6.2.4.1. Growth in awareness and increase in research activities are key factors driving market growth
  • 6.2.5. OTHER CRISPR PRODUCTS
• 6.3. CRISPR SERVICES
  • 6.3.1. CRISPR SERVICES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 6.3.2. GRNA DESIGN & VECTOR CONSTRUCTION
    • 6.3.2.1. gRNA design and vector construction segment to dominate the CRISPR services market during the forecast period
  • 6.3.3. CELL LINE ENGINEERING
    • 6.3.3.1. Cell line engineering to register the highest growth in the CRISPR services market during the forecast period
  • 6.3.4. SCREENING SERVICES
    • 6.3.4.1. CRISPR screening services are required for the genome-wide interrogation of gene function
  • 6.3.5. OTHER CRISPR SERVICES

7. CRISPR TECHNOLOGY MARKET, BY APPLICATION

• 7.1. INTRODUCTION
• 7.2. BIOMEDICAL APPLICATIONS
  • 7.2.1. ACCELERATED PROGRESS IN GENE THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS WILL DRIVE THE CRISPR TECHNOLOGY MARKET
• 7.3. AGRICULTURAL APPLICATIONS
  • 7.3.1. AGRICULTURAL ACCELERATORS SET UP IN THE US, EUROPE, AND APAC ARE HELPING WITH THE COMMERCIALIZATION OF NEW CROPS
• 7.4. INDUSTRIAL APPLICATIONS
  • 7.4.1. START-UPS IN THE US HAVE BEEN TAKING ADVANTAGE OF THE CRISPR TECHNOLOGY FOR INDUSTRIAL APPLICATIONS
• 7.5. BIOLOGICAL RESEARCH
  • 7.5.1. PROOF-OF-CONCEPT STUDIES HELP IN DEVELOPING NEW APPLICATIONS OF CRISPR THAT CAN BE COMMERCIALIZED

8. CRISPR TECHNOLOGY MARKET, BY END USER

• 8.1. INTRODUCTION
• 8.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 8.2.1. SUCCESS OF CLINICAL TRIALS WILL PLAY A KEY ROLE IN THE CRISPR TECHNOLOGY MARKET FOR PHARMA AND BIOPHARMA COMPANIES
• 8.3. BIOTECHNOLOGY COMPANIES
  • 8.3.1. RISING INTEREST OF BIOAGRICULTURAL AND BIOINDUSTRIAL COMPANIES IN CRISPR TO SPUR MARKET GROWTH
• 8.4. ACADEMIC & RESEARCH INSTITUTES
  • 8.4.1. RESEARCH FUNDING AND COLLABORATIONS WITH COMMERCIAL ORGANIZATIONS WILL DRIVE GROWTH OF THIS SEGMENT
• 8.5. CONTRACT RESEARCH ORGANIZATIONS
  • 8.5.1. ADOPTION OF CRISPR TECHNOLOGY BY CONTRACT RESEARCH ORGANIZATIONS WILL BE KEY DRIVING FACTOR

9. CRISPR TECHNOLOGY MARKET, BY REGION

• 9.1. INTRODUCTION
• 9.2. NORTH AMERICA
  • 9.2.1. US
    • 9.2.1.1. Strong scientific and industrial base will ensure sustained growth in the years to come
  • 9.2.2. CANADA
    • 9.2.2.1. Changes in regulations will generate opportunities in the CRISPR technology market
• 9.3. EUROPE
  • 9.3.1. UK AND IRELAND
    • 9.3.1.1. High activity in the area of CRISPR and CRISPR-based research
  • 9.3.2. GERMANY
    • 9.3.2.1. Strong base of pharma companies will favor the growth of CRISPR
  • 9.3.3. FRANCE
    • 9.3.3.1. Growing support and funds for CRISPR research to support the French market
  • 9.3.4. REST OF EUROPE
• 9.4. ASIA PACIFIC
  • 9.4.1. CHINA
    • 9.4.1.1. China to register the highest growth rate in the APAC CRISPR technology market during the forecast period
  • 9.4.2. JAPAN
    • 9.4.2.1. Growing collaborations between universities and pharma/biotech companies to drive market growth
  • 9.4.3. SOUTH KOREA
    • 9.4.3.1. Strong private investments in CRISPR technology applications is the major factor driving market growth in the country
  • 9.4.4. REST OF APAC
• 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

• 10.1. MARKET OVERVIEW
• 10.2. MARKET RANKING ANALYSIS (2017)
• 10.3. COMPETITIVE SITUATION AND TRENDS
  • 10.3.1. COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
  • 10.3.2. PRODUCT LAUNCHES AND APPROVALS
  • 10.3.3. ACQUISITIONS
  • 10.3.4. PATENT APPROVALS
  • 10.3.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)^*

• 11.1. THERMO FISHER SCIENTIFIC
• 11.2. MERCK KGAA
• 11.3. GENSCRIPT
• 11.4. INTEGRATED DNA TECHNOLOGIES (IDT)
• 11.5. HORIZON DISCOVERY GROUP
• 11.6. AGILENT TECHNOLOGIES
• 11.7. CELLECTA, INC.
• 11.8. GENECOPOEIA, INC.
• 11.9. NEW ENGLAND BIOLABS
• 11.10. ORIGENE TECHNOLOGIES, INC.
• 11.11. SYNTHEGO CORPORATION
• 11.12. TOOLGEN, INC.

^*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

• 12.1. DISCUSSION GUIDE
• 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.4. AVAILABLE CUSTOMIZATIONS
• 12.5. RELATED REPORTS
• 12.6. AUTHOR DETAILS

LIST OF TABLES

• TABLE 1: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 2: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 3: CRISPR PRODUCTS MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 4: CRISPR ENZYMES MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 5: CRISPR LIBRARIES MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 6: CRISPR KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 7: SGRNA DESIGN TOOLS
• TABLE 8: OTHER CRISPR PRODUCTS MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 9: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 10: CRISPR SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 11: CRISPR GRNA DESIGN AND VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 12: CRISPR CELL LINE ENGINEERING SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 13: CRISPR SCREENING SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 14: OTHER CRISPR SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 15: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 16: CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
• TABLE 17: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 18: EUROPE: CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 19: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 20: CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
• TABLE 21: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 22: EUROPE: CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 23: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 24: CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
• TABLE 25: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 26: EUROPE: CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 27: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
• TABLE 28: CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH, BY REGION, 2016-2023 (USD MILLION)
• TABLE 29: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 30: EUROPE: CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 31: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 32: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 33: CRISPR: CLINICAL PIPELINE
• TABLE 34: CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2016-2023 (USD MILLION)
• TABLE 35: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 36: EUROPE: CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 37: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 38: LIST OF SOME OF THE AGRICULTURAL AND INDUSTRIAL CRISPR-BASED PRODUCTS/APPLICATIONS
• TABLE 39: CRISPR TECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2023 (USD MILLION)
• TABLE 40: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 41: EUROPE: CRISPR TECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 42: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 43: LIST OF SOME OF THE MAJOR RESEARCH COLLABORATIONS IN THE CRISPR TECHNOLOGY MARKET, 2015-2018
• TABLE 44: CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
• TABLE 45: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 46: EUROPE: CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 47: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 48: CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016-2023 (USD MILLION)
• TABLE 49: NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 50: EUROPE: CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 51: ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 52: CRISPR TECHNOLOGY MARKET, BY REGION, 2016-2023 (USD MILLION)
• TABLE 53: NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 54: NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 55: NORTH AMERICA: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 56: NORTH AMERICA: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 57: NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 58: NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 59: US: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 60: US: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 61: US: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 62: US: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 63: US: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 64: CANADA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 65: CANADA: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 66: CANADA: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 67: CANADA: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 68: CANADA: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 69: EUROPE: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 70: EUROPE: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 71: EUROPE: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 72: EUROPE: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 73: EUROPE: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 74: EUROPE: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 75: UK AND IRELAND: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 76: UK AND IRELAND: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 77: UK AND IRELAND: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 78: UK AND IRELAND: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 79: UK AND IRELAND: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 80: GERMANY: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 81: GERMANY: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 82: GERMANY: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 83: GERMANY: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 84: GERMANY: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 85: FRANCE: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 86: FRANCE: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 87: FRANCE: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 88: FRANCE: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 89: FRANCE: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 90: LIST OF MEETINGS, CONFERENCE, AND WORKSHOPS ON CRISPR IN ROE 2016-2018
• TABLE 91: ROE: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 92: ROE: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 93: ROE: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 94: ROE: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 95: ROE: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 96: APAC: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
• TABLE 97: APAC: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 98: APAC: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 99: APAC: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 100: APAC: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 101: APAC: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 102: CHINA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 103: CHINA: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 104: CHINA: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 105: CHINA: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 106: CHINA: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 107: JAPAN: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 108: JAPAN: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 109: JAPAN: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 110: JAPAN: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 111: JAPAN: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 112: SOUTH KOREA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 113: SOUTH KOREA: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 114: SOUTH KOREA: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 115: SOUTH KOREA: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 116: SOUTH KOREA: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 117: ROAPAC: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 118: ROAPAC: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 119: ROAPAC: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 120: ROAPAC: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 121: ROAPAC: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 122: ROW: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
• TABLE 123: ROW: CRISPR PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 124: ROW: CRISPR SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
• TABLE 125: ROW: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
• TABLE 126: ROW: CRISPR TECHNOLOGY MARKET, BY END USER, 2016-2023 (USD MILLION)
• TABLE 127: CRISPR TECHNOLOGY MARKET RANKING, BY KEY PLAYER (2017)
• TABLE 128: COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS (2015-2018)
• TABLE 129: PRODUCT LAUNCHES (2015-2018)
• TABLE 130: ACQUISITIONS, 2015-2018
• TABLE 131: PATENT APPROVALS (2015-2018)
• TABLE 132: OTHER DEVELOPMENTS (2015-2018)

LIST OF FIGURES

• FIGURE 1: RESEARCH DESIGN
• FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY SIZE, DESIGNATION, AND REGION
• FIGURE 3: MARKET DATA TRIANGULATION METHODOLOGY
• FIGURE 4: CRISPR TECHNOLOGY MARKET, BY PRODUCT AND SERVICE, 2018 VS. 2023 (USD MILLION)
• FIGURE 5: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
• FIGURE 6: CRISPR TECHNOLOGY MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
• FIGURE 7: GEOGRAPHICAL SNAPSHOT OF THE CRISPR TECHNOLOGY MARKET
• FIGURE 8: GROWTH OF THIS MARKET IS EXPECTED TO BE DRIVEN BY THE RISING AVAILABILITY OF FUNDING AND GROWING APPLICATIONS OF CRISPR
• FIGURE 9: PHARMA AND BIOPHARMA COMPANIES ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF EUROPEAN MARKET IN 2018
• FIGURE 10: BIOMEDICAL APPLICATIONS ARE EXPECTED TO ACCOUNT SHARE OF THE MARKET IN 2018
• FIGURE 11: CRISPR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 12: TIMELINE FOR MAJOR EVENTS IN CRISPR PATENT WAR
• FIGURE 13: CRISPR PRODUCTS TO ACCOUNT FOR THE LARGER SHARE OF THE CRISPR TECHNOLOGY MARKET IN 2018
• FIGURE 14: CRISPR TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• FIGURE 15: NORTH AMERICAN CRISPR TECHNOLOGY MARKET SNAPSHOT
• FIGURE 16: EUROPE: CRISPR TECHNOLOGY MARKET SNAPSHOT
• FIGURE 17: APAC: CRISPR TECHNOLOGY MARKET SNAPSHOT
• FIGURE 18: KEY DEVELOPMENTS IN THE CRISPR TECHNOLOGY MARKET (2015-2018)
• FIGURE 19: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
• FIGURE 20: MERCK KGAA: COMPANY SNAPSHOT (2017)
• FIGURE 21: GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2017)
• FIGURE 22: HORIZON DISCOVERY GROUP PLC: COMPANY SNAPSHOT (2017)
• FIGURE 23: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2017)
• FIGURE 24: TOOLGEN: COMPANY SNAPSHOT (2017)